Fertility and Sterility
Volume 94, Issue 4 , Pages 1292-1295 , September 2010

Multivariate analysis of the association between oocyte donor characteristics, including basal follicle stimulating hormone (FSH) and age, and IVF cycle outcomes

Data from the following study were presented in part at the American Society for Reproductive Medicine Annual Meeting, San Francisco, November 2008.

  • Sara E. Barton, M.D.

      Affiliations

    • Division of Reproductive Medicine, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationReprint requests: Sara E. Barton, M.D., Gynecology Services, ASB1-3, 75 Francis Street, Boston, MA 02115 (FAX: 617-975-0966).
    • ,
  • Stacey A. Missmer, Sc.D.

      Affiliations

    • Division of Reproductive Medicine, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
    • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
    • Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts
    • ,
  • Rachel K. Ashby, M.D.

      Affiliations

    • Division of Reproductive Medicine, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
    • ,
  • Elizabeth S. Ginsburg, M.D.

      Affiliations

    • Division of Reproductive Medicine, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

Received 18 April 2009 ,Revised 14 July 2009 ,Accepted 21 July 2009.

References 

  1. Soceity for Assisted Reproductive Technology (SART). All SART member clinics: Clinic Summary Report, 2007. https://www.sart.org.
  2. Faber BM, Mercan R, Hamacher P, Muasher S, Toner J. The impact of egg donor's age and her prior fertility on recipient pregnancy outcome. Fertil Steril. 1997;68:370–372
  3. Shulman A, Frenkel Y, Dor J, Levran D, Shiff E, Maschiachi S. The best donor. Hum Reprod. 1999;14:2493–2496
  4. Harris SE. Analysis of donor heterogeneity as a factor affecting the clinical outcome of oocyte donation. Hum Fertil. 2002;4:193–198
  5. Cohen MA, Lindheim SR, Sauer MV. Donor age is paramount to success in oocyte donation. Hum Reprod. 1999;14:2755–2758
  6. Wong IL, Legro RS, Lindheim SR, Paulson RJ, Sauer MV. Efficacy of oocytes donated by older women in an oocyte donation programme. Hum Reprod. 1996;11:820–823
  7. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718
  8. Mirkin S. Factors associated with an optimal pregnancy outcome in an oocyte donation program. J Assist Reprod Genet. 2003;20:400–408
  9. Weghofer A, Margreiter M, Fauster Y, Schaetz T, Brandstetter A, Boehm D, et al. Age-specific FSH levels as a tool for appropriate counseling in assisted reproduction. Hum Reprod. 2005;20:2448–2452

 S.E.B. has nothing to disclose. S.A.M. has nothing to disclose. R.K.A. has nothing to disclose. E.S.G. has nothing to disclose.

PII: S0015-0282(09)03465-7

doi: 10.1016/j.fertnstert.2009.07.1672

Fertility and Sterility
Volume 94, Issue 4 , Pages 1292-1295 , September 2010

Article Tools